Cyprus Mail
AsiaWorld

WHO gives emergency approval to Sinopharm, first Chinese jab

The World Health Organization announced on Friday it had approved a COVID-19 vaccine from China’s state-owned drugmaker Sinopharm for emergency use.

The vaccine, one of two main Chinese shots that collectively have already been given to hundreds of millions of people in China and abroad, becomes the first COVID-19 shot developed by a non-Western country to win the WHO’s backing.

It is also the first time the WHO has given emergency use approval to any Chinese vaccine for any infectious disease.

A WHO emergency listing is a signal to national regulators on a product’s safety and efficacy, and would allow the shot to be included in COVAX, the global programme to provide vaccines mainly for poor countries.

The WHO has previously given emergency approval to COVID-19 vaccines developed by Pfizer-BioNTech, AstraZeneca, Johnson & Johnson, and, last week, Moderna.

Follow the Cyprus Mail on Google News

Related Posts

Authorities warned of ship approach moments before Baltimore bridge collapse

Reuters News Service

Lebanon’s Hezbollah says it launched dozens of rockets after Israeli strikes

Reuters News Service

Trump’s media company surges for second day after stellar debut

Reuters News Service

Migrant crossings to UK hit new record, heaping pressure on Sunak

Reuters News Service

Israeli strikes on Rafah raise fear assault could begin

Reuters News Service

Officials board ship that hit Baltimore bridge, divers search for bodies

Reuters News Service